Medical Robots: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
Medical Robots
Largest movements
- Receivables within one year -€42,651
down €42,651 (-64.6%), from €66,035 to €23,384
of which Other amounts receivable: -€29,282
- Cash -€20,720
down €20,720 (-95.7%), from €21,660 to €940
mainly Other debts (-€64,983) and Net result for the year (-€7,391)
- Intangible fixed assets -€7,315
down €7,315 (-17.4%), from €42,008 to €34,693
- Tangible fixed assets -€3,136
down €3,136 (-29.7%), from €10,542 to €7,407
- Other debts -€64,983
down €64,983 (-41.3%), from €157,171 to €92,187
- Profit (loss) carried forward -€7,391
down €7,391 (-16.2%), from -€45,573 to -€52,964
- Trade debts -€1,447
down €1,447 (-14.6%), from €9,897 to €8,450
- Gross operating margin -€324
down €324 (-8.9%), from €3,622 to €3,298
- Financial income +€232
new in 2025: €232
- Financial charges -€219
down €219 (-75.7%), from €290 to €70
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €140,245 | €66,424 | -€73,821 | -52.6% |
| Fixed assets | 21/28 | €52,550 | €42,100 | -€10,451 | -19.9% |
| Intangible fixed assets | 21 | €42,008 | €34,693 | -€7,315 | -17.4% |
| Tangible fixed assets | 22/27 | €10,542 | €7,407 | -€3,136 | -29.7% |
| Plant, machinery and equipment | 23 | €10,542 | €7,407 | -€3,136 | -29.7% |
| Current assets | 29/58 | €87,695 | €24,324 | -€63,371 | -72.3% |
| Amounts receivable within one year | 40/41 | €66,035 | €23,384 | -€42,651 | -64.6% |
| Trade receivables | 40 | €30,750 | €17,380 | -€13,369 | -43.5% |
| Other amounts receivable | 41 | €35,285 | €6,003 | -€29,282 | -83.0% |
| Cash at bank and in hand | 54/58 | €21,660 | €940 | -€20,720 | -95.7% |
| Total equity and liabilities | 10/49 | €140,245 | €66,424 | -€73,821 | -52.6% |
| Equity | 10/15 | -€26,823 | -€34,214 | -€7,391 | -27.6% |
| Contributions | 10/11 | €18,750 | €18,750 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€45,573 | -€52,964 | -€7,391 | -16.2% |
| Amounts payable | 17/49 | €167,068 | €100,638 | -€66,431 | -39.8% |
| Amounts payable within one year | 42/48 | €167,068 | €100,638 | -€66,431 | -39.8% |
| Trade debts | 44 | €9,897 | €8,450 | -€1,447 | -14.6% |
| Suppliers | 440/4 | €9,897 | €8,450 | -€1,447 | -14.6% |
| Other amounts payable | 47/48 | €157,171 | €92,187 | -€64,983 | -41.3% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €10,451 | €10,451 | = | 0.0% |
| Other operating charges | 640/8 | €387 | €400 | +€12 | +3.2% |
| Gross operating margin | 9900 | €3,622 | €3,298 | -€324 | -8.9% |
| Operating profit (loss) | 9901 | -€7,216 | -€7,553 | -€337 | -4.7% |
| Financial income | 75/76B | - | €232 | +€232 | |
| Recurring financial income | 75 | - | €232 | +€232 | |
| Financial charges | 65/66B | €290 | €70 | -€219 | -75.7% |
| Recurring financial charges | 65 | €290 | €70 | -€219 | -75.7% |
| Profit (loss) for the period before taxes | 9903 | -€7,506 | -€7,391 | +€115 | +1.5% |
| Profit (loss) for the period | 9904 | -€7,506 | -€7,391 | +€115 | +1.5% |
| Profit (loss) for the period to be appropriated | 9905 | -€7,506 | -€7,391 | +€115 | +1.5% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 24 October 2026 via checked.be.